Vol. 76 PHOSPHOLIPIDS OF HUMAN PLASMA 475 SUMMARY 1. The analysis, by silica-gel chromatography, of phospholipids from a human-plasma fraction is described. The fraction was derived from whole blood which had been incubated with sodium [Me-14C]acetate for 6-5 hr. The #-lipoproteins had been removed by precipitation with dextran sulphate.
Human y-globulin is known to be heterogeneous according to several immunological and physicochemical criteria. Nevertheless, the labelled protein appears to be eliminated from plasma at a constant rate after the initial phase of equilibration between intra-and extra-vascular pools and this suggests that the molecules have a uniform metabolic fate (Myant, 1952; Dixon, Talmage, Maurer & Deichmiller, 1952; Volwiler et al. 1955) . Turnover studies based on plasma-elimination data alone cannot, however, detect minor components which are rapidly broken down during the phase of equilibration; nor do such studies constitute a sensitive means of detecting a steady fall in the rate of breakdown such as might occur with a mixed population of molecules.
For assessing the metabolic homogeneity of plasma-protein preparations, radioactive iodine offers advantages over other isotopes. 131I liberated during catabolism is not re-incorporated into protein and, provided that adequate amounts of inactive iodide are administered, the radioactive isotope is quantitatively excreted in the urine (Cohen, Holloway, Matthews & McFarlane, 1956 ). Daily turnover rates can be calculated by expressing excreted radioactivity as a fraction of the labelled protein remaining in the plasma (McFarlane, 1957) . The turnover rate of albumin measured by this method remains constant during 4 weeks of observation in healthy human subjects (S. Cohen, T. Freeman & A. S. McFarlane, unpublished work) ; turnover rates of y-globulin, on the other hand, decline progressively both in man and in laboratory animals (McFarlane, 1957) .
We have applied this test of metabolic homogeneity to several different preparations of human y-globulin. The results obtained with fractions prepared by electrophoresis and ion-exchange chromatography, as well as with y-macroglobulin separated by ultracentrifuging, are described below. METHODS Subject8. This study was carried out on fourteen men and one woman (ages 19-76 years) . Ten appeared to be in perfect health and were members of the hospital or laboratory staff. The remaining five were patients who had been convalescent for 2-4 weeks before the present investigation was started (Table 1) .
Preparation of y-globulin fractions. y-Globulin was prepared from the blood of seven different healthy donors by the following methods.
(a) Zone electrophoresis. A globulin precipitate was obtained from human serum by adding 26% (w/v) Na2SO4
to give a final concentration of 16% of Na2SO4; the precipitate was dissolved in 09% NaCl solution, dialysed (Porath, 1956) . The column measured 40 cm. x 2-5 cm. and was surrounded by a jacket through which tap water was circulated. The eluate was collected in volumes of 4 ml. and protein peaks were located by measurement of the ultraviolet absorption at 280 m, of volumes (4 ml.) of eluate. The pooled yglobulin (Fig. I a) was concentrated by pressure dialysis at 40; this fraction contained 13.6% of the serum protein applied to the column. y-Globulin was also prepared by zone electrophoresis of 6 ml. of human serum without preliminary salt fractionation and with a cellulose column 83 cm. x 3 cm. This y-globulin fraction, pooled as shown in Fig. 1 Peterson & Sober (1956) . A volume of normal human serum (42 ml.) containing 3 g. of protein was decreased to 27 ml. by pressure dialysis against 5 mn-sodium phosphate buffer, pH 7-1; 9% of the protein precipitated during dialysis and the remainder was applied to a column (38 cm. x 2-5 cm.) contaiing 35 g. of cellulose. The buffer used was 5 mxphosphate, pH 7-1, with a gradient to 0-3x-Na&HPO4; the volume of the mixing chamber was 1100 ml The ultraviolet absorption of volumes (4 ml.) of the eluate was measured at 280 miu and y-globulin fractions were pooled as shown in Fig. 2a with a gradient to 0-3M-NaH2PO4; the volume of the mixing chamber was 1100 ml. y-Globulin fractions were pooled as shown in Fig. 2 b. Fraction A contained 3.5 % of the original serum protein and on rechromatography was identical with fraction A of the previous preparation (Fig. 2a) (Behringwerke, Marburg-Lahn) in an attempt to prevent denaturation (Muller-Eberhard, Kunkel & Franklin, 1956 albumin, ou-macroglobulin and y-macroglobulin were localized by measurement of radioactivity. The y-macroglobulin, which contained 14% of the 181I, was pooled as shown in Fig. 3 , added to 100 mg. of human albumin (Lister Institute, Elstree, Herts), concentrated by pressure dialysis and passed through a Seitz filter before injection.
Iodination. Protein solutions were labelled with carrierfree 181I or 125I supplied by The Radiochemical Centre, Amersham, Bucks, free from reducing agent and condensed into 002N-NaOH. Iodine monochloride was used as the inactive carrier solution according to the method of McFarlane (1958) . Free iodide was removed from labelled protein solutions by passage through anion-exchange columns of De-Acidite (The Permutit Co. Ltd., London, W. 4). After the labelling, 40-0% of the initial radioactivity passed through the column and less than 1B5% of this was present in the supernatant after precipitation with 10% (w/v) trichloroacetic acid. The mean ratio, iodine bound: protein (mol.wt. 150 000) was 1-1 5 g.atom/ mole. The labelled proteins were collected in 5 % albumin (Lister Institute, Elstree, Herts) and passed through a Seitz filter before injection.
Measurement of radioactivity. 181I and 128J were measured by scintillation counting with a well-type NaI crystal and a pulse-height analyser having a 9 v channel width. Measurements of ""LI were made with the channel in the region of the 0-36 Mev y-ray peak and 1251I was measured in the region of the 0-035 Mev peak. In the samples which contained both isotopes 1251 measurements were corrected for lsI counts (equivalent to 18-5-20 % of the count rate observed in the 181I channel). 13'I measurements, on the other hand, did not require correction for 125J, as all 400 Vol. of eluate (ml.) Fig. 3 . Zone electrophoresis of a 131I-labelled macroglobulin preparation which contained some added human albumin. About 10 mg. of labelled macroglobulin was mixed with 3 ml. of human serum. The labelled y-macroglobulin which was concentrated by pressure dialysis is indicated by the shaded area. *, Radioactivity; 0, extinction.
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METABOLISM OF HUMAN y-GLOBULIN batches of the latter isotope, when used, gave a negligible counting rate in this channel (less than 0*2 % of the rate observed in the 125I channel). The standard deviation of counts recorded in this study did not exceed ±3 %. Hexo8amine e8timationw. These were performed by the method of Rondle & Morgan (1955) after hydrolysis of y-globulin in 4N-HCl for 4 hr.
Paper electrophoresis. Serum samples were analysed by paper electrophoresis according to the method of Jencks, Jetton & Durrum (1955) and the proportion of y-globulin was estimated by the elution of strips stained with bromophenol blue. The distribution of radioactivity along strips was determined by scanning before a Geiger counter shielded by lead with a 1-5 mm. window and connected to a ratemeter with pen recorder.
Ultracentrifugal analysis. Solutions containing approx.
10 mg. of protein/ml. were dialysed against 0-15M-NaCl and examined at room temperature in a Spinco model E ultracentrifuge. Sedimentation coefficients expressed as Svedberg units and corrected to 20°(S20, ) were calculated according to the method described by Charlwood (1955) . Experimental procedure. Subjects received NaI (45 mg./ day) for 2 days before the injection of labelled y-globulin and subsequently throughout the period of blood sampling. A volume of 2-5 ml. of labelled y-globulin (2-8 mg. of protein) was injected into the antecubital vein; residual radioactivity retained in the syringe, needle and ampoule was measured and the dose injected (Table 1) calculated by difference. Blood samples were collected into tubes containing 0.05 ml. of heparin (5000 i.u./ml.). The first was taken 5-10 min. after injection and subsequent samples were collected at intervals of 1-2 days for up to 6 weeks (Table 1) . Plasma-protein concentration was determined by a biuret method (Gornall, Bardawill & David, 1949) . Radioactivity measurements were made on samples (2 ml.) of plasma and expressed as Fc/ml.; during the initial 5 days in which measurements could be made less than 1-5 % of the plasma radioactivity was present in the supernatant after precipitation with trichloroacetic acid at a final concentration of 10 %. Collection of pooled 24 hr. samples of urine was continued for 14-25 days; the radioactivity of samples (2 ml.) was measured. In two experiments (A 10 and A 1) the faeces contained 0 7-0 9 % of the total radioactivity excreted during the first 5 days; faecal analyses were not performed in subsequent experiments.
Analysis of data. The following calculations were made:
Plasma volume = Injected dose (pc) Plasma radioactivity (e&c/ml.) after 5-10 min. Plasma-protein mass = plasma vol. x protein concn. Plasma-y-globulin mass = plasma-protein mass x % of y-globulin (by paper electrophoresis).
Total body radioactivity = injected radioactivitycumulative urinary excretion of labelled I.
Extravascular radioactivity = total body radioactivity -intravascular radioactivity. The fractional turnover rate (fraction of the total or intravascular y-globulin broken down per day) and the mass ratio of extra-to intra-vascular y-globulin were calculated by the following methods.
(i) From the slope of the plasma specific activity curve (Sterling, 1950) .
(ii) By analysis at the 'equilibrium time', i.e. the time at which total activity in the extravascular pool reaches a maximum. As shown by Campbell, Cuthbertson, Matthews & McFarlane (1956) there is no net transfer of radioactivity between intra-and extra-vascular compartments at this time. The rate of change of plasma specific activity at the equilibrium time is therefore equal to the fractional turnover rate and the ratio of intra-to extra-vascular total activities provides a measure of the mass ratio of protein in the two compartments (Fig. 6) .
(iii) By resolution of the plasma specific activity curve into two or more exponential functions of time; the rate constants of the system are calculated from the slopes and coefficients of these exponentials (Matthews, 1957) . In the present study this analysis was performed by means of an analogue computer in which pool masses and exchange rates are simulated by means of a capacity resistance network (Perkins & Piper, 1959) . The plasma specific activity curve was drawn on a graticule in front of the cathode-ray tube and the electrical parameters were adjusted to match the experimental curve. Pool masses were then derived from the relative values of the capacities; the resistance values gave the fractional turnover rate as well as exchange rates between pools.
(iv) Fractional turnover, rates were also calculated from the daily urinary excretion of radioactive iodine expressed as a fraction of the mean total intravascular radioactivity during the corresponding period. RESULTS y-Globulin prepared by electrophore8is. y-Globulin prepared by electrophoresis showed one predominant component in the ultracentrifuge (S20, w 6-75) and about 5 % of heavier material (S20 w 19). The hexosamine content was 1-48 % (Table 2 ). The 1311-labelled protein was mixed with serum and analysed by paper electrophoresis; radioactivity was confined to the y-globulin region (Fig. 4) . On chromatographic analysis the labelled y-globulin was widely distributed (Fig. 5) ; 64 % of the eluted radioactivity emerged with the initial y-globulin peaks, 25 % was associated with P-globulin and 9 % was eluted beyond the albumin peak in the region of the eluate which contained y-macroglobulin (see below). The ,-globulin area of the chromatogram (Fig. 5, 240-280 ml. of the eluate) was concentrated by pressure dialysis, mixed with unlabelled serum and analysed by paper Table 2 . Hexosamine content and sedimentation coefficient8 of y-globulin preparations A, B and C refer to chromatographic fractions (Fig. 2b) . Vol. 76 479 S. COHEN AND T. FREEMAN electrophoresis; radioactivity was again found to be confined to y-globulin. Three subjects received 13L1-labelled y-globulin prepared by sodium sulphate precipitation and electrophoresis; two were injected with material prepared by electrophoresis alone (Table 1) 1-1 ,-fEhc',,p. etlch.>f 7,-TfJeobu-1rit; activities plotted on a semi-logarithmic scale showed the usual rapid initial decrease associated with mixing of labelled molecules with extravascular protein (Fig. 6a ). This phase was followed after 7-10 days by an apparently linear rate of decrease; half-lives calculated from this portion of the plasma curve varied from 15 to 21 days (mean 18 days). The apparent mass ratio of extra-to . Electrophoretic analysis and radioactive assay of labelled y-globulin preparations. A tracer amount of each labelled y-globulin preparation (see Methods section) was added to normal human serum and analysed by paper electrophoresis. The distribution of radioactivity on the paper strips was determined by scanning before a Geiger counter shielded by lead with a 1-5 mm. window. 200 400 600 Vol. of eluate (ml.) Fig. 5 . Chromatographic analysis and radioactive assay of labelled y-globulin preparations added to normal human serum. Protein distribution in normal serum is shown above. Less than 1 mg. of labelled y-globulin was mixed with 10 ml. of human serum and analysed on 20 g. cellulose columns. The buffer was 5 mM-phosphate, pH 7-1, except with the electrophoretic fraction, in which 001xM-phosphate, pH 8-3,wasused; thegradientwasto03m-NaH,PO,. Radioactivity was measured by scintillation counting on volumes (2 ml.) of the eluate. intra-vascular y-globulin, estimated by extrapolation of the linear portion of the plasma specific activity curve, was 1-2-1-6 (mean 1-4). Extravascular !activity increased progressively to reach a maximum value after 3-5 days and thereafter declined more slowly than the intravascular activity.
Between 5-6 and 7-9 % of the injected 1311 was excreted in the urine within 24 hr. (Table 1 ). In the three subjects injected with y-globulin prepared by sodium sulphate precipitation and electrophoresis, the fractional turnover rate calculated from the urinary excretion of 1311 declined progressively for 11-13 days (Fig. 7) ; strict control of urine collection was not possible in these subjects. The experiment was therefore repeated in two hospitalized subjects in whom urine collection was supervised (Expts. A10, All, in Table 1 ). yGlobulin prepared by zone electrophoresis was used; in both experiments the fractional turnover rate fell progressively for 7 days and then remained constant during a further week of observation (Fig. 7) . y-Globulin prepared by chromatography. The three subfractions of y-globulin prepared by chromatography and referred to as fractions A, B and C (Fig. 2) contained no rapidly sedimenting material when examined in the ultracentrifuge and each appeared as a single symmetrical peak; S20 X values were between 6-10 and 6-62 (Table 2 ).
The hexosamine content of these fractions increased progressively from 1-18 to 1-62 % (Table 2) ; this finding could be correlated with increasing electrophoretic mobility (Fig. 5) and progressively later elution from the chromatographic column. 31
Fraction A, when labelled and re-examined by chromatography, was confined to the first peak, fraction B emerged partly with p-globulin and fraction C extended to the albumin peak (Fig. 5) .
12 -Na2SO4 precipitation and electrophoresis 
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Five subjects were injected with either fraction A or B labelled with ""'I (Table 1) ; results obtained in an experiment with fraction A are shown in Fig. 6b . The turnover rate in all experiments was relatively constant throughout and did not show the initial progressive fall observed with electrophoretic yglobulin (Fig. 7) . The mean turnover rate varied from 5-2 to 8-4 % in three subjects who received fraction A, and from 8-1 to 8-3 % in two subjects injected with fraction B. Individual variation made it impossible to decide whether the two fractions were broken down at significantly different rates in healthy subjects. Fractions A and B were therefore separately labelled with either lsLI or 12I, injected together and turnover rates compared directly in two subjects (Table 1 and Fig. 8 , Expts. A68 and A80). In both experiments the two fractions were eliminated from the plasma at identical rates. In Expt. A80 (Fig. 8 ) in which urine analyses were performed, the excretion of "III (fraction B) exceeded that of 1"5I (fraction A) by 3 8 % of the dose during the first 3 days of the experiment; thereafter, the excretion rates of the two isotopes were closely similar. The initial difference was probably due to the presence of denatured material in the L311-labelled protein as a similar result was observed in another subject given the same preparation. In Expt. A85 (Fig. 8) fractions A and C prepared by salt precipitation and chromatography (Fig. 2b) gave identical plasma elimination curves and fractional turnover rates throughout.
Different methods of analysis gave similar values for the fractional turnover rate and distribution ratio of chromatographic y-globulin (Table 3 ). The turnover rate was relatively high in the three convalescent patients (A 16, A23 and A 24) . In the remaining eight experiments performed on five normal subjects, the half-life of y-globulin was 21-26 days (mean 23 days). The mass ratio of extra-to intra-vascular y-globulin was 0-6-1 1 (mean 10) and the exchange rate between intraand extra-vascular pools was equivalent to 25%
(range 19-33%) of the circulating y-globulin per day. Estimates of the absolute breakdown rate calculated from the slope of the plasma specific activity curve were always about 10 % higher than values obtained by three other methods; the latter gave an absolute rate of 15-2-5 g./day (mean 2* 1 g./day).
y-Macroglobulin. The y-macroglobulin prepared by ultracentrifuging and zone electrophoresis had an electrophoretic mobility similar to that of fraction B described above (Fig. 4) . On chromatographic analysis, however, the macroglobulin was widely separated from y-fractions of lower molecular weight and was eluted in the region beyond the albumin peak (Fig. 5) . Two subjects were injected with 131I-labelled y-macroglobulin (Table 1 , A53 and A90). The distribution and turnover of this protein was strikingly different from other y-globulin fractions studied (Fig. 9) . The total radioactivity and intravascular radioactivity declined at similar rates and the slightly higher level of the former during the first 3 days can probably be attributed to the diffusion into the extravascular fluid of free iodine liberated during protein breakdown. This data A80 A85 elimination rate of the minor component (Table 4) .
This rate was similar for both experiments (Fig. Time (days) 10a) and approximated to the observed elimination Fig. 9 . Total body and intravascular radioactivity and rate of y-macroglobulin (Fig. lOb) .
fractional turnover rate in a subject (A53) injected with
In one subject (A90) 1311-labelled y-macro-"III-labelled y-macroglobulin. (Cohen & Gordon, 1958) . The validity of metabolic data obtained with 131I-labelled proteins has been questioned in recent years (Goldsworthy & Volwiler, 1957) . Studies in this Laboratory, however, have shown in animals that the behaviour of 131I-labelled albumin and globulin is almost identical with that of the same proteins biosynthetically labelled with 14C (Cohen et al. 1956; Campbell et al. 1956 ). Moreover, the elimination of 14C-and 13I-labelled antibody globulins is identical either in the presence or absence of an immune response (McFarlane, 1957; Humphrey, 1957) . More recently, it has been shown that a subject with congenital analbuminaemia eliminated 131I-labelled and unlabelled albumin at the same rate (Freeman, Matthews, McFarlane, Bennhold & Kallee, 1959; Bennhold & Kallee, 1959) .
These experiments show that the radioactive iodine, attached under defined conditions, can be used as a reliable indicator of the metabolic behaviour of unlabelled protein molecules. In this connexion it may be noted that half-lives in this study fall within the range observed with biosynthetically labelled y-globulin (Volwiler et at. 1955) . The initial fall in the fractional turnover rate of electrophoretic y-globulin therefore indicates that this preparation contains molecules which, in the native state, would have different rates of breakdown. This labelled y-globulin had a wide distribution on chromatographic analysis corresponding with that described for unlabelled human yglobulin (Fahey, McCoy & Goulian, 1958) ; the chromatographic similarity of 131-labelled and unlabelled human albumin has been demonstrated (Cohen, 1959) .
Turnover rates were constant with three chromatographic subfractions of y-globulin and each must be regarded as metabolically homogeneous. The fact that a constant fraction of the plasma radioactivity was excreted each day, even during the process of equilibration between intra-and extra-vascular pools, indicates that y-globulin breakdown occurs at a site in close functional proximity to the bloodstream; the same conclusion has been reached about the site of albumin catabolism (Berson & Yalow, 1954; Campbell et al. 1956; Lewallen, Berman & Rall, 1959) . With a double-labelling technique the three chromatographic fractions were shown to have identical plasma-elimination and turnover rates. These fractions contained 10% of the serum protein applied to chromatographic columns from which the total recovery of protein was about 75 %; taken together the fractions cover 90% of the electrophoretic y-globulin chromatogram (Fig. 5) . The results therefore indicate that the bulk of human y-globulin has a uniform distribution and breakdown rate despite the fact that it can be resolved by chromatography into subfractions which have different electrophoretic mobility, total hexose (Fahey & Horbett, 1959) and hexosamine content, and distinct immunological activity (Humphrey & Porter, 1957; Sober & Peterson, 1958; Fahey & Horbett, 1959) . This conclusion concerning the metabolic homogeneity of the bulk of human y-globulin is not in accordance with the observation that individual antibodies are degraded at significantly different rates in hypo-yglobulinaemic patients injected with pooled human y-globulin (Martin, Gordon, Felts & McCullough, 1957) .
The behaviour of the three chromatographic fractions does not explain the metabolic heterogeneity of electrophoretic y-globulin. None of the chromatographic fractions contained macroglobulin, which was found to be eluted late in the chromatogram; other macroglobulin preparations have shown similar chromatographic behaviour on diethylaminoethylcellulose (Lospalluto & Ziff, 1959; Fahey & Horbett, 1959) . Interpretation of the y-macroglobulin turnover data must be qualified by the fact that the protein may have been altered during the repeated process of preparative ultracentrifuging despite the precautions taken to prevent denaturation. Thus the declining fractional turnover rate does not necessarily indicate that native macroglobulin would show similar metabolic heterogeneity. The fact that the elimination was initially somewhat faster than the theoretical rate (Fig. 10b ) may be due to partial denaturation of the macroglobulin; similarly, the fractional turnover rate during the first 6 days fell more rapidly with a mixture of chromatographic and macroglobulin than with electrophoretic yglobulin (Fig. 7) . In most forms of denaturation altered protein molecules are very rapidly removed from the circulation (Freeman, 1959) . The fact that the breakdown rate in two subjects was equivalent to 15-18 % of the intravascular pool per day after 5-7 days indicates that the macroglobulin in its native form has a turnover rate at least three times as great as y-globulin of smaller molecular size. A similar difference in the half-lives of smalland large-molecular-weight antibodies has been reported in rabbits (Taliaferro & Talmage, 1956) .
The macroglobulin also differed from smallermolecular-weight y-globulin in its failure to penetrate into extravascular tissues. This apparent inability to pass across capillaries can be explained Vol. 76 485
